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Abstract 
Background: Two sets of diagnostic criteria of paediatric multiple organ dysfunction syndrome (MODS) were pub‑
lished by Proulx in 1996 and by Goldstein in 2005. We hypothesized that this changes the epidemiology of MODS. 
Thus, we determined the epidemiology of MODS, according to these two sets of diagnostic criteria, we studied the 
intra‑ and inter‑observer reproducibility of each set of diagnostic criteria, and we compared the association between 
cases of MODS at paediatric intensive care unit (PICU) entry, as diagnosed by each set of diagnostic criteria, and 
90‑day all‑cause mortality.
Methods: All consecutive patients admitted to the tertiary care PICU of Sainte‑Justine Hospital, from April 21, 2009 to 
April 20, 2010, were considered eligible for enrolment into this prospective observational cohort study. The exclusion 
criteria were gestational age < 40 weeks, age < 3 days or > 18 years at PICU entry, pregnancy, admission immediately 
after delivery. No patients were censored. Daily monitoring using medical chart ended when the patient died or was 
discharged from PICU. Mortality was monitored up to death, hospital discharge, or 90 days post PICU entry, whatever 
happened first. Concordance rate and kappa score were calculated to assess reproducibility. The number of MODS 
identified with Proulx and Goldstein definitions was compared using 2‑by‑2 contingency tables. Student’s t test or 
Wilcoxon signed‑ranked test was used to compare continuous variables with normal or abnormal distribution, respec‑
tively. We performed a Kaplan–Meier survival analysis to assess the association between MODS at PICU entry and 
90‑day mortality.
Results: The occurrence of MODS was monitored daily and prospectively in 842 consecutive patients admitted to 
the PICU of Sainte‑Justine Hospital over 1 year. According to Proulx and Goldstein diagnostic criteria, 180 (21.4 %) 
and 314 patients (37.3 %) had MODS over PICU stay, respectively. Concordance of MODS diagnosis over PICU stay 
was 81.3 % (95 % CI 78.6–83.9 %), and kappa score was 0.56 (95 % CI 0.50–0.61). Discordance was mainly attributable 
to cardiovascular or neurological dysfunction criteria. The proportion of patients with MODS at PICU entry who died 
within 90 days was higher with MODS diagnosed with Proulx criteria (17.8 vs. 11.5 %, p = 0.038), as well as the likeli‑
hood ratio of death (4.84 vs. 2.37). On the other hand, 90‑day survival rate of patients without MODS at PICU entry was 
similar (98.6 vs. 98.9 % (p = 0.73).
Conclusions: Proulx and Goldstein diagnostic criteria of paediatric MODS are not equivalent. The epidemiology of 
paediatric MODS varies depending on which set of diagnostic criteria is applied.
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Background
Multiple organ dysfunction syndrome (MODS), a com-
mon and deadly condition, is frequently observed in 
paediatric intensive care units (PICU) [1]. The patho-
physiology of MODS is characterized by a severe, sys-
temic, somewhat uncontrolled inflammatory process 
that leads to multiple organ or system dysfunctions [2]. 
There is a consensus that MODS should be diagnosed 
when the dysfunction of at least two organs or systems is 
simultaneously observed. On the other hand, there is no 
consensus on the criteria that must be used to diagnose 
the organ dysfunctions. The diagnostic criteria of MODS 
changed over time. A first set of diagnostic criteria was 
proposed in 1986 by Wilkinson [3], which was updated 
in 1996 by Proulx [4]. In 2005 following an international 
symposium on sepsis and MODS, experts presented a 
revised set of diagnostic criteria, authored by Goldstein 
[5, 6]. The goal of this 2005 definition was to “identify a 
reproducible assessment of organ dysfunction that allows 
for tracking of changes in organ function, both improve-
ment and deterioration”.
These sets of diagnostic criteria of paediatric MODS 
are used in the medical literature. In this study, we deter-
mined the epidemiology of MODS, according to the sets 
of diagnostic criteria of Proulx [4] and Goldstein [5, 6], 
we studied the intra- and inter-observer reproducibility 
of each set of diagnostic criteria, and we compared the 
association between cases of MODS at paediatric inten-
sive care unit (PICU) entry, as diagnosed by each set of 
diagnostic criteria, and 90-day all-cause mortality.
Methods
Study population
All consecutive patients admitted to the tertiary care 
PICU of Sainte-Justine Hospital (Montreal, Canada), 
from 21 April 2009 to 20 April 2010, were considered eli-
gible for enrolment into this prospective observational 
cohort study. The exclusion criteria were: gestational 
age less than 40 weeks, age less than 3 days or more than 
18  years at PICU entry, pregnancy, admission immedi-
ately after delivery. The research ethics board of Sainte-
Justine Hospital approved waived consent for this study.
Data collection
Validated case report forms were filled by PICU research 
assistants. Time zero for each patient was the day of 
PICU entry, and daily monitoring using medical chart of 
each individual case ended when the patient died or was 
discharged from PICU. We used calendar days (actuarial 
approach), which means that the time of data collection 
on day 1 and on day of PICU discharge was shorter than 
24  h. Readmission within 24  h of discharge from PICU 
was considered as a single PICU stay. Mortality was 
assessed up to hospital discharge or up to 90 days post-
PICU entry, whatever happened first.
Definition of MODS
MODS is defined as the concurrent dysfunction of two 
or more organs or systems including respiratory, car-
diovascular, haematological, neurological, gastrointes-
tinal, hepatic and renal. In this study, we compared the 
diagnostic criteria suggested in 1996 by Proulx [4] and 
in 2005 by Goldstein [5, 6] (these two sets of diagnostic 
criteria are detailed in the Additional file 1). In both sets, 
one to five parameters are used to define each organ dys-
function, which is diagnosed if at least one criterion per 
organ is met. Some important differences between the 
two definitions should be underlined. For example, the 
diagnostic criteria of Proulx include gastrointestinal dys-
function, which was not retained by Goldstein. Moreo-
ver, Proulx set of criteria uses two age strata (less than 
1 year old or more than 1 year old) to define low blood 
pressure, bradycardia and tachycardia. Heart rate is not 
retained in Goldstein set of criteria, but it uses six differ-
ent strata of age to define normal blood pressure.
Patients with “new MODS” included (1) children with 
no organ dysfunction at PICU entry who developed two 
or more concurrent organ dysfunction while in PICU, 
or (2) children with only one organ dysfunction at PICU 
entry who subsequently developed concurrently at least 
another organ dysfunction. “Progressive MODS” was 
diagnosed when a patient with MODS at PICU entry (i.e. 
concurrent dysfunction of two or more organ systems) 
died subsequently or developed at least one additional 
organ dysfunction.
Statistical analysis
Descriptive statistics included number and proportions 
(%), likelihood ratio, odds ratio, 95 % confidence interval 
(95 % CI) and mean ± standard deviation (SD).
To assess intra-observer reproducibility, a research 
assistant (Marianna Dumitrescu) filled twice, at least 
2  months apart, the case report form of 100 randomly 
selected patients. In order to evaluate inter-observer 
reproducibility, two different observers (Marianna 
Dumitrescu and Marilyn Gaudreau) filled the case report 
form of the same 100 patients. The number of MODS 
identified with Proulx and Goldstein definitions was 
compared using 2-by-2 contingency tables. Concordance 
rate and kappa score (қ) were calculated to assess intra- 
and inter-observer reproducibility of MODS diagnosis 
with both sets of criteria.
Student’s t test or Wilcoxon signed-ranked test was 
used to compare continuous variables with normal or 
abnormal distribution, respectively. The association 
between MODS diagnosis at PICU entry and 90-day 
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mortality was assessed by performing a Kaplan–Meier 
survival analysis. No patients were censored: all were 
monitored up to death, hospital discharge or 90  days 
post-PICU entry, whatever happened first.
Type 1 error was fixed at 5 %; p value <0.05 was consid-
ered statistically significant. The data were analysed using 
the statistical software SAS program (SAS, release 9.3, 
SAS Institute Inc., Cary, NC, USA).
Results
Over the 1-year study period, there were 913 consecutive 
PICU admissions at Sainte-Justine Hospital. We excluded 
71 because of gestational age <40 weeks (n = 41), because 
of age at PICU entry <3  days or >18  years (n =  40) or 
because the patient was admitted immediately after 
delivery (n = 1); more than one exclusion criterion was 
noted in some patients. Demographic information about 
the 842 PICU patients retained in the study is reported in 
Table 1.
Epidemiology
Using Proulx and Goldstein diagnostic criteria, the 
number of patients with MODS during PICU stay 
was 180 (180/842  =  21.4  %) and 314 (37.3  %), respec-
tively (Table  1). We observed new MODS in 56 
(56/842 = 6.7 %) and 65 children (7.7 %) and progressive 
MODS in 109 (12.9 %) and 104 patients (12.4 %), respec-
tively. The proportion of MODS diagnosed at PICU 
entry that developed into progressive MODS was 87.9 % 
(109/124) and 41.8  % (104/249) with Proulx and Gold-
stein criteria, respectively. The incidence rate of new and 
progressive MODS was 19.6 and 20.1 % with Proulx and 
Goldstein definitions, respectively.
Reproducibility
Reproducibility was tested in 100 patients. The inter-
observer concordance rate of MODS diagnosis was 93 % 
(kappa: 0.84; 95 % CI 0.72–0.95) using Proulx criteria and 
93  % (kappa: 0.86; 95  % CI 0.76–0.96) using Goldstein 
criteria. Intra-observer reproducibility was 89 % (kappa: 
0.74; 95 % CI 0.59–0.88) vs. 90 % (kappa: 0.80; 95 % CI 
0.68–0.92).
Concordance of diagnostic criteria
We calculate concordance and kappa score to estimate 
whether MODS or a given organ dysfunction was diag-
nosed twice or not diagnosed twice by the same observer 
in the same patients, using in the same patients the two 
sets of diagnostic criteria (inter-tests reproducibility). 
Concordance in 842 patients between Proulx and Gold-
stein MODS diagnosis at PICU entry was 81 % (95 % CI 
79–84  %) and the kappa score was 0.49 (95  % CI 0.43–
0.56) (Table 2). The concordance and kappa score for new 
Table 1 Population description
Number (%) or mean ± SD
ECMO extracorporeal membrane oxygenation, MODS multiple organ 
dysfunction syndrome, PELOD paediatric logistic organ dysfunction, PICU 
paediatric intensive care unit, PRISM paediatric risk of mortality
a MODS (Proulx): cases of MODS diagnosed during PICU stay, using diagnostic 
criteria advocated by Proulx in 1996 [4]
b MODS (Goldstein): cases of MODS diagnosed during PICU stay, using 
diagnostic criteria advocated by Goldstein in 2005 [5, 6]
c Include patients with and without MODS
d There were many causes of admission in some patients





 Male 98 (54.5) 168 (53.5) 434 (51.5)
 Age (months) 60 ± 72 64 ± 70 72 ± 72
Severity of illness at 
PICU entry
 PRISM score 11.4 ± 7.8 9.2 ± 7.1 6.0 ± 5.8
 Daily PELOD score 10.3 ± 9.4 8.1 ± 8.4 4.8 ± 6.8




76 (42.2) 146 (46.8) 298 (36.4)
 Shock
  Hypovolemic 
shock
10 (5.6) 10 (3.2) 19 (2.5)
  Septic shock 17 (9.6) 19 (6.1) 27 (3.2)
  Haemorrhagic 
shock
4 (2.5) 5 (1.6) 5 (1.6)
  Cardiogenic 
shock
13 (7.5) 13 (4.2) 15 (1.8)
 Congenital heart 
disease
29 (16.3) 39 (12.6) 77 (9.2)
 Bacterial infection 70 (39.1) 125 (39.9) 237 (28.2)
 Viral infection 46 (25.8) 97 (31.1) 203 (24.2)
 Trauma
  Polytraumatism 4 (2.2) 11 (3.5) 18 (2.4)
  Severe head 
trauma
6 (3.3) 10 (3.1) 11 (1.3)
  Burn 2 (1.1) 2 (0.6) 5 (0.6)
 Surgery
  Post‑cardiac 
surgery
22 (12.3) 38 (12.1) 105 (12.5)
  Other surgery 
(planned)
17 (9.5) 33 (10.5) 146 (17.4)
  Other surgery 
(unplanned)
14 (7.8) 24 (7.7) 63 (7.5)
 Other reasons for 
admission
91 (50.6) 145 (46.2) 368 (43.8)
Specific treatment 
during PICU stay
 ECMO 7 (3.9) 7 (2.3) 7 (0.8)
 Haemofiltration 6 (3.3) 7 (2.3) 7 (0.8)
 Haemodialysis 10 (5.5) 9 (2.9) 15 (1.5)
 At least 1 red cell 
transfusion
91 (50.6) 101 (32.2) 142 (16.9)
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(93  %) and progressive MODS (89  %) were high, with 
similar kappa scores 0.50. The concordance of the organ 
dysfunctions ranges from 67  % (neurological) to 99  % 
(renal dysfunction); the kappa scores range from 0.17 
(cardiovascular) to 0.91 (renal dysfunction).
Mortality associated with MODS
Forty-two patients (42/842  =  5.0  %) died, 28 
(28/42 = 66.7 %) during their PICU stay and 41 (97.6 %) 
within 90  days after PICU entry (one patient died after 
more than 90  days). The 90-day all-cause mortality was 
higher when MODS was diagnosed at PICU entry using 
Proulx criteria (17.8 vs. 11.5 %, p = 0.038); likewise, the 
likelihood ratio of death in patients with MODS at PICU 
entry was higher with Proulx criteria (4.84 vs. 2.37). On 
the other hand, the 90-day survival rate of patients with-
out MODS at PICU entry was similar (98.6 vs. 98.9  % 
(p = 0.73). There was a statistically significant difference 
between the survival curves of the two definitions for 
patients with MODS (p < 0.001) (Fig. 1).
Discussion
Epidemiology
MODS is a syndrome. By definition, a syndrome is a 
group of symptoms and signs that consistently occur 
Table 2 Inter-test reproducibility of two sets of diagnostic criteria of MODS in 842 consecutive PICU patients
95 % CI 95 % confidence interval
MODS multiple organ dysfunction syndrome, PICU paediatric intensive care unit
a Diagnostic criteria of MODS advocated by Proulx in 1996 [4]
b Diagnostic criteria of MODS advocated by Goldstein in 2005 [5, 6]
c Concordance and kappa score estimate whether a given organ dysfunction was diagnosed twice or not diagnosed twice by the same observer in the same patients 
(inter-tests reproducibility), using in the same patients the two sets of diagnostic criteria of Proulx and Goldstein
d According to Kramer [21], a kappa score is considered slight if <0.2, fair if between 0.2 and 0.4, moderate if between 0.4 and 0.6, substantial if between 0.6 and 0.8 
and almost perfect if >0.8
e Progressive MODS can happen only in patients with MODS at PICU admission
Diagnosis of MODS or organ dysfunction in 842 patients
Proulx, patientsa Goldstein patientsb Concordancec p value Kappa scorec,d
MODS during PICU stay
1. MODS at PICU admission 124 (14.7 %) 249 (29.6 %) 81 % <0.001 0.49 (0.43–0.56)
Progressive MODSe 109 (12.9 %) 104 (12.4 %) 89 % <0.001 0.50 (0.42–0.59)
2. New MODS 56 (6.7 %) 65 (7.7 %) 93 % <0.001 0.50 (0.39–0.61)
MODS during PICU stay (1 + 2) 180 (21.4 %) 314 (37.3 %) 80 % <0.001 0.56 (0.50–0.61)
Organ dysfunction during PICU stay
Respiratory 317 (37.7 %) 373 (44.3 %) 92 % <0.001 0.85 (0.81–0.88)
Cardiovascular 125 (14.9 %) 15 (1.8 %) 86 % <0.001 0.17 (0.09–0.25)
Haematological 93 (11.1 %) 122 (14.5 %) 90 % <0.001 0.55 (0.46–0.63)
Neurological 150 (17.8 %) 428 (50.8 %) 67 % <0.001 0.34 (0.30–0.39)
Gastrointestinal 13 (1.5 %) Not applicable – – –
Hepatic 65 (7.7 %) 107 (12.7 %) 93 % <0.001 0.62 (0.54–0.71)















Days after PICU admission
No MODS at PICU entry
(Proulx Criteria) 
MODS at PICU entry (Proulx Criteria) 
MODS at PICU entry (Goldstein Criteria) 
No MODS at PICU entry
(Goldstein Criteria) 
Fig. 1 Survival analysis. Survival among 842 children with or without 
MODS at PICU entry, as defined by Proulx [4] or by Goldstein [5, 
6]; no patient was lost or censored. There are four Kaplan–Meier 
curves: (1) patients without MODS, as diagnosed by the Goldstein 
diagnostic criteria (upper hatched curve); (2) patients without MODS, 
as diagnosed using Proulx diagnostic criteria (upper plain curve); 
(3) patients with MODS, as diagnosed by the Goldstein diagnostic 
criteria (lower hatched curve); (4) patients with MODS, as diagnosed by 
the Proulx diagnostic criteria (lower plain curve). There is a statistically 
significant difference between the two survival curves of patients 
with MODS according to Proulx and Goldstein definitions (lowest two 
curves) (p < 0.001). MODS multiple organ dysfunction syndrome, PICU 
paediatric intensive care unit
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together or a condition characterized by a set of associ-
ated symptoms and signs that is so common that it can-
not be attributed to hazard. In theory, the diagnosis of a 
syndrome like MODS could be based on clinical and/or 
laboratory data. In practice, we do not have a pathogno-
monic laboratory test that can be used as a gold stand-
ard to diagnose MODS. Therefore, MODS is presently a 
clinical diagnosis that is based on lists of criteria.
Two sets of diagnostic criteria are currently used in the 
medical literature: one was published by Proulx [4] and 
the other one by Goldstein [5, 6]. In our hands, the inci-
dence of MODS was 21.4 and 37.3 % with the diagnostic 
criteria of Proulx and Goldstein, respectively. This impor-
tant difference in the incidence rate of MODS diagnosed 
by these two sets of criteria is probably attributable to 
different incidence rates of cardiovascular (14.9 vs. 1.8 %) 
and neurological dysfunction (17.8 vs. 50.8 %).
Our study reports many other important epidemiologi-
cal data on paediatric MODS. In the literature, the preva-
lence and incidence rate of MODS reported in critically 
ill children while in PICU range from 6 to 71  % [7, 8]. 
Using Proulx definition, Tantalean [9] reported MODS in 
56.5 % of patients during their PICU stay; 84.6 % of these 
MODS were present at PICU entry. Applying the same 
criteria, we observed a much lower prevalence (21.4 %) of 
MODS at PICU entry.
Using Goldstein diagnostic criteria, Typpo [10] 
reported a prevalence of MODS at PICU entry of 18.6 %; 
we noted a prevalence of 37.3 %. This difference might be 
attributable to different case-mix: Typpo and colleagues 
excluded patients younger than 1  month of age, while 
we did not; moreover, they excluded all patients from 
all hospitals where more than 10  % missing values for 
MODS variables were missing.
We checked whether the prevalence in PICU of the 
individual organ dysfunction was similar with the two 
sets of criteria (Table  2). Otherwise than the cardiovas-
cular dysfunction, the prevalence during PICU stay of all 
organ dysfunctions was higher with Goldstein than with 
Proulx criteria. Using concordance and kappa score, we 
also checked whether both sets of criteria diagnosed the 
same organ dysfunction in the same patients; inter-test 
reproducibility was poor in cardiovascular (kappa = 0.17; 
95  % CI 0.09–0.25) and neurological dysfunction (0.34; 
95 % CI 0.30–0.39). This poor inter-test reproducibility is 
probably attributable to different definitions of cardiovas-
cular and neurological dysfunction. The low prevalence 
of cardiovascular dysfunction as diagnosed with Gold-
stein criteria (1.8 %) is probably explained by the fact that 
a patient should receive a fluid bolus (≥40 ml/kg) to be 
considered as having a cardiovascular dysfunction. This 
criterion may exclude patients in cardiogenic shock or 
with congenital heart disease treated with inotropes for 
which large fluid boluses are avoided. The prevalence 
of neurological dysfunction was lower with Proulx than 
with Goldstein criteria (17.8 vs. 50.8 %); this is probably 
explained by more severe criteria with the former (Glas-
gow coma score <5 or fixed dilated pupils) than with the 
latter (Glasgow coma score ≤11 or acute change in men-
tal status with a change in Glasgow coma score ≥3 points 
from abnormal baseline). Gastrointestinal dysfunction 
is only considered in the set of diagnostic criteria of 
Proulx. It is rare (1.5 %) and it did not contribute impor-
tantly to the observed discordance. The utility of includ-
ing gastrointestinal dysfunction in MODS definition is 
questionable.
Diagnosis of MODS using Proulx and Goldstein crite-
ria is not interchangeable. Weiss [11] reported a seven-
fold difference in the frequency of sepsis, using different 
definitions. Hence, any changes to the diagnostic criteria 
of a syndrome like MODS or a disease like sepsis will 
inevitably change their epidemiology. It is not rare to 
read a paper where a “modified” or “adapted” definition 
of a set of diagnostic criteria is used; this practice must 
be banned unless the new definition is well validated and 
its epidemiology well compared to the epidemiology of 
previous definitions. Practitioners and investigators must 
carefully account for variations in diagnostic methods 
when reviewing and interpreting the literature, or pre-
paring a clinical trial.
New and progressive MODS was used as a composite 
outcome measure in many randomized controlled tri-
als that enrolled critically ill patients [12–14]. Leteurtre 
[15] determined the incidence rate of MODS in 3669 
consecutive patients enrolled in two European PICUs: 
the incidence rate of new and progressive MODS was 5.5 
and 4.7 %, respectively (total: 10.2 %). Weiss [16] reported 
that 30 % of children subsequently developed new or pro-
gressive MODS after sepsis recognition. In our study, the 
incidence rate of new and progressive MODS was 19.6 
and 20.1 % with Proulx and Goldstein definitions, respec-
tively, which is quite similar; this suggests that using one 
rather than the other set of diagnostic criteria of organ 
dysfunction would not change the sample size of a ran-
domized controlled trial where the primary outcome 
measure is new or progressive MODS. On the other 
hand, the incidence rate of new or progressive MODS 
(range 10.2 and 20.1 %) is at least three times higher than 
the incidence rate of PICU mortality (2.7  %; site range 
1.3–5.0 %) reported by Pollack in 2015 in seven Ameri-
can sites [17]. Thus, choosing a composite outcome 
that includes new and progressive MODS—progres-
sive MODS containing all deaths—rather than mortality 
alone as the primary outcome measure of a randomized 
controlled trial conducted in PICU should decrease sig-
nificantly the sample size required to complete the trial.
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Test validation
A set of diagnostic criteria is a test that is used to dis-
criminate patients with or without a disease. The best 
way to validate a test is to determine its sensitivity and 
specificity, which required a gold standard able to classify 
patients in the right group (with or without the disease). 
However, there is presently no gold standard that can be 
used to differentiate patients with or without MODS. 
Therefore, we were unable to compare the sensitivity and 
specificity of the two sets of diagnostic criteria to diag-
nose MODS, using a gold standard. This is why this study 
does not tell us if the discriminative value of one set of 
diagnostic criteria is better that the other.
However, sensitivity and specificity are not the only 
parameters that can be used to validate a test: reproducibil-
ity is another important quality of a test [18, 19]. Juskewitch 
[20] reported an inter-observer agreement to diagnose pae-
diatric cases of systemic inflammatory response syndrome 
of 88 % (95 % CI 74–94) with a kappa score of 0.75 (95 % 
CI 0.59–0.92), which is considered “substantial agreement” 
[21]. We study intra- and inter-observer reproducibility 
of two sets of diagnostic criteria [5, 6]. The inter-observer 
agreement of MODS diagnosis was 93 % (kappa: 0.84; 95 % 
CI 0.72–0.95) using Proulx criteria and 93 % (kappa: 0.86; 
95 % CI 0.76–0.96) using Goldstein criteria. Intra-observer 
reproducibility was 89 % (kappa: 0.74; 95 % CI 0.59–0.88) 
vs. 90 % (kappa: 0.80; 95 % CI 0.68–0.92). Thus, inter- and 
intra-observer reproducibility of both sets of diagnostic cri-
teria was almost similar and would be considered “almost 
perfect” by experts in epidemiology [21].
Association between MODS and outcomes
A diagnosis is more useful if it is associated with predicta-
ble outcomes [22]. MODS is associated not only with short-
term mortality [10, 15, 23], but also with long-term adverse 
events, such as poor functional outcomes [10]. MODS is 
diagnosed in 66–91.5 % of patients who die in PICU [9, 10]. 
In the literature, the mortality rate of critically ill children 
having MODS ranges from 10 to 57 % [8, 10]. Tantalean [9], 
using Proulx diagnostic criteria, reported a 41.6 % mortal-
ity rate in children with MODS. Using Proulx criteria, we 
report a 90-day mortality rate of 19.8  % in patients with 
MODS at PICU entry, while it was 11.5 % (p = 0.038) using 
Goldstein criteria. On the other hand, the risk of death was 
lower in patients without MODS at PICU entry, irrespec-
tive of the definition used (Fig. 1). MODS remains highly 
associated with mortality in critically ill children, regardless 
of the set of diagnostic criteria chosen.
Strengths and limitations
The prospective design of our study is a considerable 
strength. Moreover, we enrolled consecutive PICU patients 
over a 1-year period, which enhances representativeness.
Our study has several limitations. First, one can won-
der whether it is relevant to compare two different 
sets of diagnostic criteria that were published 10  years 
apart. We believe that it is relevant because the rela-
tionship between these two sets has never been evalu-
ated. Moreover, both sets of diagnostic criteria—Proulx 
and Goldstein—are presently used [24–26]. We showed 
that these two sets do not diagnose MODS in the same 
patients, something that is frequently ignored. Second, 
we completed a single-centre study, which limits its 
external validity. However, when comparing severity of 
illness indicators and mortality rates, our PICU seems 
comparable to other level III multidisciplinary univer-
sity-affiliated centres. Third, this study does not deter-
mine which definition—Proulx or Goldstein—should be 
used to study MODS in critically ill children. However, 
it provides information on reproducibility and likelihood 
of 90-day mortality that should allow investigators and 
practitioners to choose the most appropriate set of diag-
nostic criteria of MODS, given their scientific or clinical 
objectives.
Conclusions
Different prevalence and incidence of MODS in different 
papers might be attributable to many causes: study design 
(retro- vs. prospective), different case-mix of patients, 
secular trends, detection bias, reporting bias, different 
sources of data and chance; it can also be attributable 
to the use of different diagnostic criteria [27]. Proulx [4] 
and Goldstein [5, 6] suggested two different sets of diag-
nostic criteria of paediatric MODS. These two sets are 
not equivalent. Both definitions have good inter- and 
intra-observer reproducibility, and both are closely asso-
ciated with short-term mortality. However, the associa-
tion between MODS diagnosed with Proulx criteria and 
90-day mortality was higher than with Goldstein criteria.
The diagnostic criteria of MODS can be improved; 
we can look for a better alignment between diagnosis of 
MODS and its pathophysiology (uncontrolled systemic 
inflammation) and/or a better predictive value (mortal-
ity, post-PICU sequelae, quality of life). Finding a test or 
a group of tests that can reliably support the diagnosis of 
MODS would be very useful.
Abbreviations
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